共 9 条
[1]
BEACH, 2003, CURR MED CHEM IMMUN, V3, P1233
[2]
FISHER, 2002, J NEURAL TRANSM-SUPP, V62, P189
[3]
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease
[J].
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS,
2003, 10 (01)
:1-6
[4]
Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO
[5]
2-J
[9]
SPARKS, 2003, ADPD2003 SEV MAY